Translate this page into:
Author’s Reply
Corresponding author: Dr. Tarun Narang, Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. narangtarun2012@gmail.com
-
Received: ,
Accepted: ,
How to cite this article: Bhandari A, Narang T, Panjiyar R, Dogra S, Handa S. Author’s reply. Indian J Dermatol Venereol Leprol. 2025;91:701-2. doi: 10.25259/IJDVL_978_2025
We appreciate thoughtful comments on our study examining “impact of childhood psoriasis on children and their caregivers”1 and provide following clarifications to explain our methodology and interpretations.
Cultural adaptation and contextual validity of FDLQI in Indian setting
The concern regarding the cultural adaptation of the Family Dermatology Life Quality Index (FDLQI) in India2 is valid. While formal cultural validation was not performed, using translated and validated Hindi and English versions ensured linguistic relevance. The tool captures broad domains such as emotional burden, time spent on care, and family functioning—constructs that are globally relevant. Furthermore, similar domain-level findings across studies from Turkey and Australia suggest cross-cultural applicability. Nonetheless, we recognise this as a limitation.3,4
Cross-Sectional design and causal interpretations
We acknowledge that our cross-sectional design limits causal inference. Associations, such as between joint involvement and self-consciousness (χ2=11.07, p=0.01) and between Psoriasis Area and Severity Index (PASI), Children’s Dermatology Life Quality Index (CDLQI), and FDLQI (rs=0.549 and 0.609, p=0.001), highlight a meaningful pattern. The strong correlation between CDLQI and FDLQI (rs=0.790, p<0.001) reflects shared burden in children and caregivers. Though longitudinal or comparator-group studies would better establish causality, our design provides valuable initial insights into paediatric psoriasis in India.
Disconnect between disease severity and QoL impact
The disconnect between mild-to-moderate disease severity (median PASI-3.4) and high caregiver burden (FDLQI: 96.1% affected; 25.4% with extremely large effect) reflects the stronger influence of psychosocial and socioeconomic factors over clinical severity alone. Significant associations with catastrophic health expenditure (Catastrophic Health Expenditure (CHE); 40.1%, p=0.014), treatment expense (rs=0.483, p=0.000), and exposed site involvement (p=0.003) underscore the impact of financial strain and stigma.4,5
Although caregiver income and literacy were not included in the regression, caregiver education and occupation were reported [Table 1], and treatment expense—a direct proxy for financial strain—was a significant predictor (p=0.031). Income was self-reported, a standard practice in low-resource settings, and the study provides essential context with median income (₹2,40,000) and treatment costs (₹18,500), illustrating financial vulnerability.
Arbitrary categorisation of treatment response
Treatment response was categorised as “minimal,” “moderate,” or “good” based on patient report. While this lacks standardisation, it captures patient-perceived improvement, highly relevant to quality of life. Although it may introduce misclassification bias, patient-reported outcomes are increasingly recognised for reflecting the lived experience, especially in real-world settings.6
Lack of formal mental health screening for caregivers
Given the high emotional burden FDLQI score (mean 1.75±0.88, median-2), incorporating a separate mental health screening tool would be ideal, but we explicitly state this as a limitation of our study. However, the FDLQI is a validated tool designed to assess emotional and psychosocial impacts, and its emotional domain effectively captures caregiver distress, as evidenced by 95% of caregivers reporting impairment.7 The significant correlation between FDLQI and CDLQI (rs=0.790, p=0.001) reinforces its utility in identifying caregiver burden. We agree that future studies should incorporate formal tools like Patient Health Questionnaire (PHQ-9) or General Anxiety Disorder questionnaire (GAD-7) to more comprehensively assess psychological distress.
We thank the authors for their keen interest in our work and for highlighting areas that deserve further attention. We hope our study will further stimulate researchers to explore psychosocial aspects of childhood psoriasis and its impact on their care-givers.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
Use of artificial intelligence (AI)-assisted technology for manuscript preparation
The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.
References
- Assessing the impact of childhood and adolescent chronic plaque psoriasis on parents/caregivers using the Family Dermatology Life Quality Index (FDLQI): A cross-sectional study. Indian J Dermatol Venereol Leprol.. 2025;91:569-70.
- [Google Scholar]
- Response to assessing the impact of childhood and adolescent chronic plaque psoriasis on parents/caregivers using the family dermatology life quality index (FDLQI) Indian J Dermatol Venereol Leprol.. 2025;91:693-4.
- [CrossRef] [Google Scholar]
- Assessment of quality of life in Turkish children with psoriasis and their caregivers. Pediatr Dermatol. 2018;35:651-9.
- [Google Scholar]
- Relationship between PASI and FDLQI in pediatric psoriasis, and treatments used in daily clinical practice. Australas J Dermatol.. 2021;62:190-4.
- [Google Scholar]
- Impact of childhood psoriasis on caregivers’ quality of life, measured with family dermatology life quality index. Acta Derm Venereol. 2020;100:adv00244.
- [Google Scholar]
- Patient-reported outcome measures: An overview. Br J Community Nurs. 2011;16:146-51.
- [Google Scholar]
- The family dermatology life quality index: Measuring the secondary impact of skin disease. Br J Dermatol. 2007;156:528-38.
- [Google Scholar]
